{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:07:43Z","timestamp":1761156463997},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s40618-018-0866-4","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T10:12:26Z","timestamp":1521108746000},"page":"1289-1300","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association of PON1 gene polymorphisms with polycystic ovarian syndrome risk: a meta-analysis of case\u2013control studies"],"prefix":"10.1007","volume":"41","author":[{"given":"D.","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"issue":"4","key":"866_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R (2011) Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7(4):219\u2013231. https:\/\/doi.org\/10.1038\/nrendo.2010.217","journal-title":"Nat Rev Endocrinol"},{"key":"866_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0832-1","author":"R Pasquali","year":"2018","unstructured":"Pasquali R, Gambineri A (2018) New perspectives on the definition and management of polycystic ovary syndrome. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-018-0832-1","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"866_CR3","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/eje-14-0253","volume":"171","author":"G Conway","year":"2014","unstructured":"Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R, Pfeifer M, Pignatelli D, Pugeat M, Yildiz BO (2014) The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 171(4):P1\u201329. https:\/\/doi.org\/10.1530\/eje-14-0253","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"866_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, Boivin J, Petraglia F, Wijeyeratne CN, Norman RJ, Dunaif A, Franks S, Wild RA, Dumesic D, Barnhart K (2012) Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 97(1):28\u201338. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.09.024","journal-title":"Fertil Steril"},{"issue":"3","key":"866_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40618-014-0215-1","volume":"38","author":"D Macut","year":"2015","unstructured":"Macut D, Antic IB, Bjekic-Macut J (2015) Cardiovascular risk factors and events in women with androgen excess. J Endocrinol Invest 38(3):295\u2013301. https:\/\/doi.org\/10.1007\/s40618-014-0215-1","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"866_CR6","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s40618-016-0498-5","volume":"39","author":"Z Kucukaydin","year":"2016","unstructured":"Kucukaydin Z, Duran C, Basaran M, Camlica F, Erdem SS, Basaran A, Kutlu O, Burnik FS, Elmas H, Gonen MS (2016) Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome. J Endocrinol Invest 39(10):1139\u20131148. https:\/\/doi.org\/10.1007\/s40618-016-0498-5","journal-title":"J Endocrinol Invest"},{"key":"866_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0762-3","author":"RA Condorelli","year":"2017","unstructured":"Condorelli RA, Calogero AE, Di Mauro M, Mongioi LM, Cannarella R, Rosta G, La Vignera S (2017) Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-017-0762-3","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"866_CR8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s40618-017-0650-x","volume":"40","author":"S Behboudi-Gandevani","year":"2017","unstructured":"Behboudi-Gandevani S, Ramezani Tehrani F, Bidhendi Yarandi R, Noroozzadeh M, Hedayati M, Azizi F (2017) The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines. J Endocrinol Invest 40(8):859\u2013866. https:\/\/doi.org\/10.1007\/s40618-017-0650-x","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"866_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-016-0523-8","volume":"40","author":"K Polak","year":"2017","unstructured":"Polak K, Czyzyk A, Simoncini T, Meczekalski B (2017) New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Invest 40(1):1\u20138. https:\/\/doi.org\/10.1007\/s40618-016-0523-8","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"866_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/humupd\/dmi025","volume":"11","author":"E Diamanti-Kandarakis","year":"2005","unstructured":"Diamanti-Kandarakis E, Piperi C (2005) Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Hum Reprod Update 11(6):631\u2013643. https:\/\/doi.org\/10.1093\/humupd\/dmi025","journal-title":"Hum Reprod Update"},{"issue":"3","key":"866_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1365-2265.2011.04218.x","volume":"76","author":"M Huang","year":"2012","unstructured":"Huang M, Xiao J, Zhao X, Liu C, Chen Q (2012) Four polymorphisms of the CAPN 10 gene and their relationship to polycystic ovary syndrome susceptibility: a meta-analysis. Clin Endocrinol 76(3):431\u2013438. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04218.x","journal-title":"Clin Endocrinol"},{"issue":"6","key":"866_CR12","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1210\/jc.2005-1494","volume":"91","author":"JM Vink","year":"2006","unstructured":"Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI (2006) Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 91(6):2100\u20132104. https:\/\/doi.org\/10.1210\/jc.2005-1494","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"866_CR13","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3109\/09513591003649823","volume":"26","author":"P Christopoulos","year":"2010","unstructured":"Christopoulos P, Mastorakos G, Gazouli M, Deligeoroglou E, Katsikis I, Diamanti-Kandarakis E, Panidis D, Creatsas G (2010) Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact? Gynecol Endocrinol 26(9):698\u2013703. https:\/\/doi.org\/10.3109\/09513591003649823","journal-title":"Gynecol Endocrinol"},{"issue":"7","key":"866_CR14","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/humrep\/deh900","volume":"20","author":"CJ Petry","year":"2005","unstructured":"Petry CJ, Ong KK, Michelmore KF, Artigas S, Wingate DL, Balen AH, de Zegher F, Ibanez DB, Dunger L (2005) Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women. Hum Reprod (Oxford, England) 20(7):1837\u20131843. https:\/\/doi.org\/10.1093\/humrep\/deh900","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"4","key":"866_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/molehr\/gap089","volume":"16","author":"JQ Zhu","year":"2010","unstructured":"Zhu JQ, Zhu L, Liang XW, Xing FQ, Schatten H, Sun QY (2010) Demethylation of LHR in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome. Mol Hum Reprod 16(4):260\u2013266. https:\/\/doi.org\/10.1093\/molehr\/gap089","journal-title":"Mol Hum Reprod"},{"issue":"2","key":"866_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/10408360802610878","volume":"46","author":"J Camps","year":"2009","unstructured":"Camps J, Marsillach J, Joven J (2009) The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci 46(2):83\u2013106. https:\/\/doi.org\/10.1080\/10408360802610878","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"7","key":"866_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2169\/internalmedicine.37.581","volume":"37","author":"T Sakai","year":"1998","unstructured":"Sakai T, Matsuura B, Onji M (1998) Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus. Intern Med (Tokyo, Japan) 37(7):581\u2013584","journal-title":"Intern Med (Tokyo, Japan)"},{"issue":"9","key":"866_CR18","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.freeradbiomed.2004.07.034","volume":"37","author":"M Mackness","year":"2004","unstructured":"Mackness M, Mackness B (2004) Paraoxonase 1 and atherosclerosis: is the gene or the protein more important? Free Radic Biol Med 37(9):1317\u20131323. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2004.07.034","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"866_CR19","first-page":"879","volume":"52","author":"IV Fenkci","year":"2007","unstructured":"Fenkci IV, Serteser M, Fenkci S, Kose S (2007) Paraoxonase levels in women with polycystic ovary syndrome. J Reprod Med 52(10):879\u2013883","journal-title":"J Reprod Med"},{"issue":"3","key":"866_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.pathophys.2009.11.004","volume":"17","author":"AM Mohamadin","year":"2010","unstructured":"Mohamadin AM, Habib FA, Elahi TF (2010) Serum paraoxonase 1 activity and oxidant\/antioxidant status in Saudi women with polycystic ovary syndrome. Pathophysiology 17(3):189\u2013196. https:\/\/doi.org\/10.1016\/j.pathophys.2009.11.004","journal-title":"Pathophysiology"},{"issue":"6","key":"866_CR21","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1086\/320600","volume":"68","author":"VH Brophy","year":"2001","unstructured":"Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE (2001) Effects of 5\u2032 regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet 68(6):1428\u20131436. https:\/\/doi.org\/10.1086\/320600","journal-title":"Am J Hum Genet"},{"issue":"1","key":"866_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.fertnstert.2015.03.037","volume":"104","author":"R Dadachanji","year":"2015","unstructured":"Dadachanji R, Shaikh N, Khavale S, Patil A, Shah N, Mukherjee S (2015) PON1 polymorphisms are associated with polycystic ovary syndrome susceptibility, related traits, and PON1 activity in Indian women with the syndrome. Fertil Steril 104(1):207\u2013216. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.03.037","journal-title":"Fertil Steril"},{"issue":"4","key":"866_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1530\/eje-14-0863","volume":"172","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Liu H, He J, Xu K, Bai H, Wang Y, Zhang F, Zhang J, Cheng L, Fan P (2015) Lactonase activity and status of paraoxonase 1 in Chinese women with polycystic ovarian syndrome. Eur J Endocrinol 172(4):391\u2013402. https:\/\/doi.org\/10.1530\/eje-14-0863","journal-title":"Eur J Endocrinol"},{"key":"866_CR24","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19(1):41\u201347","DOI":"10.1093\/humrep\/deh098"},{"key":"866_CR25","first-page":"377","volume-title":"Polycystic ovary syndrome","author":"J Zawadzki","year":"1992","unstructured":"Zawadzki J, Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens J, Haseltine F, Haseltine G (eds) Polycystic ovary syndrome, 1st edn. Oxford, England, Blackwell Scientific, pp 377\u2013384","edition":"1"},{"issue":"9","key":"866_CR26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603\u2013605. https:\/\/doi.org\/10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"866_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188","journal-title":"Control Clin Trials"},{"issue":"4","key":"866_CR28","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719\u2013748","journal-title":"J Natl Cancer Inst"},{"issue":"7109","key":"866_CR29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed) 315(7109):629\u2013634","journal-title":"BMJ (Clinical research ed)"},{"issue":"4","key":"866_CR30","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088\u20131101","journal-title":"Biometrics"},{"issue":"6","key":"866_CR31","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1210\/jc.2003-031252","volume":"89","author":"JL San Millan","year":"2004","unstructured":"San Millan JL, Corton M, Villuendas G, Sancho J, Peral B, Escobar-Morreale HF (2004) Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J Clin Endocrinol Metab 89(6):2640\u20132646. https:\/\/doi.org\/10.1210\/jc.2003-031252","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"866_CR32","first-page":"3346","volume":"3","author":"A Mohamed","year":"2009","unstructured":"Mohamed A, Rashed L, Salam R (2009) Effect of paraoxonase gene polymorphisms on paraoxonase levels and insulin resistance index in women with polycystic ovary syndrome. Aust J Basic Appl Sci 3(4):3346\u20133351","journal-title":"Aust J Basic Appl Sci"},{"issue":"1","key":"866_CR33","first-page":"24","volume":"42","author":"F Zhang","year":"2011","unstructured":"Zhang F, Liu H, Fan P, Bai H, Song Q (2011) The \u2212\u2009108C\/T polymorphism in paraoxonase 1 gene in Chinese patients with polycystic ovary syndrome. J Si Chuan Univ (Med Sci Edi) 42(1):24\u201328","journal-title":"J Si Chuan Univ (Med Sci Edi)"},{"issue":"5","key":"866_CR34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1530\/eje-11-0986","volume":"166","author":"Y Wang","year":"2012","unstructured":"Wang Y, Liu H, Fan P, Bai H, Zhang J, Zhang F (2012) Evidence for association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome in southwest Chinese women. Eur J Endocrinol 166(5):877\u2013885. https:\/\/doi.org\/10.1530\/eje-11-0986","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"866_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/cen.12139","volume":"79","author":"G Paltoglou","year":"2013","unstructured":"Paltoglou G, Tavernarakis G, Christopoulos P, Vlassi M, Gazouli M, Deligeoroglou E, Creatsas G, Mastorakos G (2013) PON1-108 TT and PON1-192 RR genotypes are more frequently encountered in Greek PCOS than non-PCOS women, and are associated with hyperandrogenaemia. Clin Endocrinol 79(2):259\u2013266. https:\/\/doi.org\/10.1111\/cen.12139","journal-title":"Clin Endocrinol"},{"issue":"2","key":"866_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3892\/br.2013.214","volume":"2","author":"P Ferk","year":"2014","unstructured":"Ferk P, Gersak K (2014) Association of \u2212\u2009108 C>T PON1 polymorphism with polycystic ovary syndrome. Biomed Rep 2(2):255\u2013259. https:\/\/doi.org\/10.3892\/br.2013.214","journal-title":"Biomed Rep"},{"issue":"9","key":"866_CR37","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3109\/09513591003686387","volume":"26","author":"A Lenarcik","year":"2010","unstructured":"Lenarcik A, Bidzinska-Speichert B, Tworowska-Bardzinska U (2010) The role of chronic inflammation and Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary syndrome. Gynecol Endocrinol 26(9):673\u2013683. https:\/\/doi.org\/10.3109\/09513591003686387","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"866_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s40618-016-0582-x","volume":"40","author":"U Durmus","year":"2017","unstructured":"Durmus U, Duran C, Ecirli S (2017) Visceral adiposity index levels in overweight and\/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters. J Endocrinol Invest 40(5):487\u2013497. https:\/\/doi.org\/10.1007\/s40618-016-0582-x","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"866_CR39","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1365-2605.2005.00623.x","volume":"29","author":"S Franks","year":"2006","unstructured":"Franks S, McCarthy MI, Hardy K (2006) Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Androl 29(1):278\u2013285. https:\/\/doi.org\/10.1111\/j.1365-2605.2005.00623.x (discussion 286\u2013290)","journal-title":"Int J Androl"},{"issue":"1\u20132","key":"866_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2009.09.025","volume":"410","author":"B Goswami","year":"2009","unstructured":"Goswami B, Tayal D, Gupta N, Mallika V (2009) Paraoxonase: a multifaceted biomolecule. Clin Chim Acta Int J Clin Chem 410(1\u20132):1\u201312. https:\/\/doi.org\/10.1016\/j.cca.2009.09.025","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"3\u20134","key":"866_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jmb.2012.02.042","volume":"418","author":"M Ben-David","year":"2012","unstructured":"Ben-David M, Elias M, Filippi JJ, Dunach E, Silman I, Sussman JL, Tawfik DS (2012) Catalytic versatility and backups in enzyme active sites: the case of serum paraoxonase 1. J Mol Biol 418(3\u20134):181\u2013196. https:\/\/doi.org\/10.1016\/j.jmb.2012.02.042","journal-title":"J Mol Biol"},{"issue":"1","key":"866_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2010.08.076","volume":"214","author":"LP Precourt","year":"2011","unstructured":"Precourt LP, Amre D, Denis MC, Lavoie JC, Delvin E, Seidman E, Levy E (2011) The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis 214(1):20\u201336. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.08.076","journal-title":"Atherosclerosis"},{"issue":"5\u20136","key":"866_CR43","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/10937400903158409","volume":"12","author":"G Ginsberg","year":"2009","unstructured":"Ginsberg G, Neafsey P, Hattis D, Guyton KZ, Johns DO, Sonawane B (2009) Genetic polymorphism in paraoxonase 1 (PON1): population distribution of PON1 activity. J Toxicol Environ Health Part B 12(5\u20136):473\u2013507. https:\/\/doi.org\/10.1080\/10937400903158409","journal-title":"J Toxicol Environ Health Part B"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-018-0866-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0866-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0866-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T19:31:15Z","timestamp":1570908675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-018-0866-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["866"],"URL":"https:\/\/doi.org\/10.1007\/s40618-018-0866-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"assertion":[{"value":"20 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors stated that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Since this is a meta-analysis informed consent is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}